Skip to content
April 29, 2024
Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity
read more
April 29, 2024
Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets
read more
April 29, 2024
Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy
read more
April 29, 2024
Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy
read more
April 29, 2024
Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model
read more
April 29, 2024
A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors
read more
March 12, 2024
Patient-derived Organoids: a powerful preclinical platform for de-risking immuno-oncology therapies
read more